Xvivo Perfusion (Q4 Initial take): Alive and kicking - Redeye
We expect a strong positive share price reaction today of c15%, given the beat on sales, profitability and a positive free cash flow. We will return with a more in-depth take on the Q4 report shortly.
ANNONS
We expect a strong positive share price reaction today of c15%, given the beat on sales, profitability and a positive free cash flow. We will return with a more in-depth take on the Q4 report shortly.
